The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year.
Droz-Perroteau C, Dureau-Pournin C, Vespignani H, Marchal C, Blin P, Blazejewski S, Pollet C, Jové J, Robinson P, Moore N, Fourrier-Réglat A; EULEV Study Group.
Droz-Perroteau C, et al. Among authors: vespignani h.
Br J Clin Pharmacol. 2011 Jan;71(1):121-7. doi: 10.1111/j.1365-2125.2010.03805.x.
Br J Clin Pharmacol. 2011.
PMID: 21143508
Free PMC article.